Compare Summit Therapeutics Inc (SMMT) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs Tempus AI — how do they compare? Summit Therapeutics Inc trades at $15.34 (market cap $12.06B), while Tempus AI trades at $55.7 (market cap $10.05B). The key difference: Summit Therapeutics Inc is the larger of the two by market cap. Which is the better fit depends on your goals.
| SMMT | TEM | |
|---|---|---|
Market Cap | $12.06B | $10.05B |
Sector | Health | Broad Market / Factor |
52-Week High | $26.98 | $103.25 |
52-Week Low | $12.55 | $41.55 |
Enterprise Value | $11.39B | $10.68B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
